Eyenovia Inc

NASDAQ:EYEN USA Biotechnology
Market Cap
$73.30 Million
Market Cap Rank
#22548 Global
#7970 in USA
Share Price
$14.36
Change (1 day)
-9.23%
52-Week Range
$0.92 - $15.82
All Time High
$15.82
About

Eyenovia, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vi… Read more

Eyenovia Inc (EYEN) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of March 2025: 0.457x

Based on the latest financial reports, Eyenovia Inc (EYEN) has a cash flow conversion efficiency ratio of 0.457x as of March 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.44 Million) by net assets ($-9.71 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Eyenovia Inc - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Eyenovia Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Eyenovia Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eyenovia Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Eyenovia Inc (2015–2024)

The table below shows the annual cash flow conversion efficiency of Eyenovia Inc from 2015 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $-13.10 Million $-30.12 Million 2.300x +186.83%
2023-12-31 $9.00 Million $-23.84 Million -2.649x -81.83%
2022-12-31 $17.23 Million $-25.11 Million -1.457x -42.82%
2021-12-31 $20.47 Million $-20.87 Million -1.020x -144.49%
2020-12-31 $15.30 Million $-6.38 Million -0.417x +74.11%
2019-12-31 $11.74 Million $-18.92 Million -1.611x -107.41%
2018-12-31 $16.88 Million $-13.11 Million -0.777x +16.40%
2017-12-31 $5.09 Million $-4.73 Million -0.929x +12.70%
2016-12-31 $3.01 Million $-3.20 Million -1.065x +33.35%
2015-12-31 $2.40 Million $-3.83 Million -1.597x --